Replimune Group, Inc. (REPL)

7.71 -0.33 (-4.10%) USD  |  NASDAQ  |  Jan 14, 16:00
7.72 +0.01 (+0.13%) Pre-Market: 08:23
More

Replimune Group Rent and Landing Expense (Quarterly)

Rent and Landing Expense (Quarterly) Chart

View Rent and Landing Expense (Quarterly) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Rent and Landing Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Rent and Landing Expense (Quarterly) Range, Past 5 Years

View Rent and Landing Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Rent and Landing Expense (Quarterly) Benchmarks

View Rent and Landing Expense (Quarterly) Benchmarks
Start Trial
Rapt Therapeutics, Inc. --
Olema Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade